Boston Scientific’s $3.7 Billion Acquisition of Axonics

Shearman & Sterling represented Boston Scientific Corporation in the transaction, and K&L Gates represented Axonics, Inc.Boston Scientific Corporation (NYSE: BSX) announced it has entered into a definitive agreement…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here